MELK and colorectal cancer: In 2005, MELK was first implicated in cancer in a study that reported elevated levels of MELK RNA expression in many human tumors and in a mouse colorectal cancer model, and demonstrated that MELK-targeted RNA-interference inhibited proliferation in cultured human cancer cell lines and also in a xenograft tumor model (Gray et al., 2005).